share_log

The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts

The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts

7位专家眼中的globus medical分析师意见
Benzinga ·  10/14 17:00
Across the recent three months, 7 analysts have shared their insights on Globus Medical (NYSE:GMED), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月,7位分析师分享了他们对globus medical(纽交所:GMED)的见解,表达了从看好到看淡的各种意见。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照,展示了情绪在过去30天中的演变情况,并将其与之前的月份进行比较。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $80.43, with a high estimate of $93.00 and a low estimate of $77.00. This upward trend is evident, with the current average reflecting a 6.43% increase from the previous average price target of $75.57.
分析师对12个月价值目标的评估提供了额外见解,展示了一个平均目标价格为80.43美元,最高估值为93.00美元,最低估值为77.00美元。这种上升趋势明显,当前平均价值较之前的75.57美元的平均目标价格增加了6.43%。
Decoding Analyst Ratings: A Detailed Look...
分析师评级解...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发